“Fluor is proud that our project and construction management services will help Baxter make this facility a reality to create therapies to treat a number of chronic and acute conditions, including immune deficiencies and critical care patients around the world,” said Steve Dobbs, president of Fluor’s industrial & infrastructure business group.
Fluor’s Greenville, S.C. office will provide support to the onsite construction management team.
The construction services company previously reserved its share of the project value in the third quarter of 2012.
The project site, located about 45 miles southeast of Atlanta, is undergoing mass excavation and earth works. At the construction’s peak, it is expected to utilize a workforce of about 2,200.
The new Baxter facility is expected to have the flexibility and necessary infrastructure to support additional global market needs when it opens in 2018.